Friday, September 17, 2021 4:09:39 PM
KATX is no longer an exploration company and LLBO is no longer a biotech. Acropolis is turning them into shells, like KAST. IF a private company buys them to reverse merge into, THAT is what they will become.
The whole point is: KAST is far more attractive reverse merger candidate. If Acropolis can't sell KAST, it's EXTREMELY unlikely they will be able to sell LLBO or KATX.
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM